SMARCB1 and bladder transitional cell carcinoma: To verify these findings, we performed transcriptomic analysis in additional previously published BLCA datasets20–22, and again consistently found that SMARCB1 low tumors were significantly enriched for the IL6/JAK/STAT3 pathway (Supplementary Fig. 2A–C; Supplementary Data 3).